5 Antiphospholipid Syndrome Clinical Trials in Portland, OR (2026)

Q: How do I join a clinical trial in Portland?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you.

Recruiting Antiphospholipid Syndrome Studies in Portland

NCT07103733Recruiting

PRIMARY Ancillary Substudy

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights in...

Portland, OR250 participantsAnnetine Gelijns

View Study Details

NCT06371417Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway...

Portland, OR144 participantsChugai Pharmaceutical

View Study Details

NCT07075185Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractory multiple myeloma....

Portland, OR70 participantsKelonia Therapeutics, Inc.

View Study Details

NCT05780034Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

This clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that c...

Portland, OR60 participantsAccutar Biotechnology Inc

View Study Details

NCT05546580Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat ...

Portland, OR50 participantsOryzon Genomics S.A.

View Study Details

About Antiphospholipid Syndrome Clinical Trials in Portland

Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.

There are currently 5 antiphospholipid syndrome clinical trials recruiting participants in Portland, OR. These studies are seeking a combined 574 participants. Research is being sponsored by Annetine Gelijns, Chugai Pharmaceutical, Kelonia Therapeutics, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Antiphospholipid Syndrome Clinical Trials in Portland — FAQ

Are there antiphospholipid syndrome clinical trials in Portland?

Yes, there are 5 antiphospholipid syndrome clinical trials currently recruiting in Portland, OR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Portland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Portland research site will contact you about next steps.

Are clinical trials in Portland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Portland studies also compensate for your time and travel.

What antiphospholipid syndrome treatments are being tested?

The 5 active trials in Portland are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.

Data updated July 13, 2026 from ClinicalTrials.gov